Olav Flaten - Hofseth Biocare Exec
| HBC Stock | NOK 1.26 0.01 0.79% |
Insider
Olav Flaten is Exec of Hofseth Biocare ASA
| Phone | 47 73 10 22 00 |
| Web | https://www.hofsethbiocare.no |
Hofseth Biocare Management Efficiency
The company has return on total asset (ROA) of (0.1942) % which means that it has lost $0.1942 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.9478) %, meaning that it generated substantial loss on money invested by shareholders. Hofseth Biocare's management efficiency ratios could be used to measure how well Hofseth Biocare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Knut Utheim | Grieg Seafood ASA | 57 | |
| Atle Sandtorv | Grieg Seafood ASA | 56 | |
| Nigel MSc | Bergenbio ASA | N/A | |
| Ole Eriksen | Navamedic ASA | 63 | |
| Gayle MBA | Bergenbio ASA | 68 | |
| Astrid Bratvedt | Navamedic ASA | N/A | |
| Kristin Eivindvik | PCI Biotech Holding | 62 | |
| Alison Messom | Bergenbio ASA | 52 | |
| Debbie Molyneux | Bergenbio ASA | N/A | |
| Cristina MD | Bergenbio ASA | N/A | |
| James Barnes | Bergenbio ASA | N/A | |
| Trond Kathenes | Grieg Seafood ASA | 61 | |
| Mattias Hartmann | Navamedic ASA | N/A | |
| Andreas Kvame | Grieg Seafood ASA | 61 | |
| Alexander Knudsen | Grieg Seafood ASA | 49 | |
| Lucy Wabakken | PCI Biotech Holding | N/A | |
| Kristina Furnes | Grieg Seafood ASA | 36 | |
| Martin Olin | Bergenbio ASA | 54 | |
| Akil Jackson | Bergenbio ASA | N/A | |
| Erik Holvik | Grieg Seafood ASA | 45 | |
| Anders Hgset | PCI Biotech Holding | 69 | |
Management Performance
| Return On Equity | -0.95 | |||
| Return On Asset | -0.19 |
Hofseth Biocare ASA Leadership Team
Elected by the shareholders, the Hofseth Biocare's board of directors comprises two types of representatives: Hofseth Biocare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Hofseth. The board's role is to monitor Hofseth Biocare's management team and ensure that shareholders' interests are well served. Hofseth Biocare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Hofseth Biocare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Angelika Florvaag, Chief Officer | ||
| Olav Flaten, Exec | ||
| Tanja Schaffer, EVP GmbH | ||
| Jon Odegard, Chief Officer | ||
| Matt Mixter, Managing America | ||
| Bomi Framroze, Chief Officer | ||
| James Berger, Chief Officer | ||
| Karl Slotsvik, Chief Officer | ||
| Crawford Currie, Head Director |
Hofseth Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Hofseth Biocare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.95 | |||
| Return On Asset | -0.19 | |||
| Profit Margin | (1.14) % | |||
| Operating Margin | (1.07) % | |||
| Current Valuation | 1.03 B | |||
| Shares Outstanding | 395.08 M | |||
| Shares Owned By Insiders | 52.50 % | |||
| Shares Owned By Institutions | 20.43 % | |||
| Price To Earning | (4.13) X | |||
| Price To Book | 5.19 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectOther Information on Investing in Hofseth Stock
Hofseth Biocare financial ratios help investors to determine whether Hofseth Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Hofseth with respect to the benefits of owning Hofseth Biocare security.